|
COPYRIGHT 2007 International Medical News Group
SAN FRANCISCO -- Patients with chronic obstructive pulmonary disease do worse when their regimens includes theophylline or ipratropium, according to two poster presentations by Todd A. Lee, Pharm. D., at the International Conference of the American Thoracic Society.
In the first study, ipratropium (Atrovent) was associated with an adjusted 45% increased relative risk of death over 2.5...
Read the full article for free courtesy of your local library.
| 
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
